Longitudinal assessment of oxaliplatin-induced neuropathy

Neurology

Volumn 78, Issue 2, 2012, Pages 152-

  Park, Susanna B ^a   Koltzenburg, Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

CLINICAL ASSESSMENT; DISEASE COURSE; DRUG INDUCED DISEASE; HUMAN; INTRAEPIDERMAL NERVE FIBER DENSITY; LONGITUDINAL STUDY; NERVE FIBER; NERVE FIBER DEGENERATION; NERVE INJURY; NEUROPATHY; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; POLYNEUROPATHY;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; ORGANOPLATINUM COMPOUNDS; POLYNEUROPATHIES;

EID: 84857432567     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000410913.88642.bf     Document Type: Editorial

References (5)

1. Burakgazi AZ, Messersmith W, Vaidya D, et al. Longitudinal assessment of oxaliplatin-induced neuropathy. Neurology 2011;77:980 -986.
2. Park SB, Lin CS, Krishnan AV, et al. Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. Oncologist 2011;16:708 -716.
3. Lauria G, Hsieh ST, Johansson O, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Eur J Neurol 2010;17:e44-e49.
4. Attal N, Bouhassira D, Gautron M, et al. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study. Pain 2009;144:245-252.
5. Land SR, Kopec JA, Cecchini RS, et al. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol 2007; 25:2205-2211. (Pubitemid 46954644)